Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States-Reference-Cited by-同舟云学术

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States

Published:2022-09-30 Issue:12 Volume:6 Page:3443-3456
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Nguyen Mindie H.¹^ORCID,Roberts Lewis R.²,Engel‐Nitz Nicole M.³,Bancroft Tim³,Ozbay A. Burak⁴,Singal Amit G.⁵^ORCID

Affiliation:

1. Department of Medicine (Gastroenterology and Hepatology) and Department of Epidemiology and Population Health Stanford University Medical Center Palo Alto California USA

2. Mayo Clinic Rochester Minnesota USA

3. Optum Eden Prairie Minnesota USA

4. Exact Sciences Corporation Madison Wisconsin USA

5. UT Southwestern Medical Center Dallas Texas USA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.2087

Reference50 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Hepatocellular carcinoma

3. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

4. Randomized controlled trial of screening for hepatocellular carcinoma

5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance;Radiology: Imaging Cancer;2024-01-01

2. Optimizing care of HBV infection and HBV-related HCC;Clinical Liver Disease;2024-01

3. Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology;Nature Reviews Gastroenterology & Hepatology;2023-08-03

4. Opportunities to address gaps in early detection and improve outcomes of liver cancer;JNCI Cancer Spectrum;2023-05-02

5. Letter: rising incidence and poor survival in patients with nonviral HCC—better HCC surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed;Alimentary Pharmacology & Therapeutics;2023-01-15